UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hematological findings and complications of COVID‐19

American journal of hematology, 2020-07, Vol.95 (7), p.834-847

2020

Volltextzugriff (PDF)

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

The oncologist (Dayton, Ohio), 2017-10, Vol.22 (10), p.1222-1231

2017

Volltextzugriff (PDF)

Updated clinical models for VTE prediction in hospitalized medical patients

Thrombosis research, 2018-04, Vol.164, p.S62-S69

2018

Volltextzugriff (PDF)

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Infection, 2021-06, Vol.49 (3), p.559-562

2021

Volltextzugriff (PDF)

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

Clinical and Applied Thrombosis/Hemostasis, 2018-12, Vol.24 (9_suppl), p.8S-28S

2018

Volltextzugriff (PDF)

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

Clinical and applied thrombosis/hemostasis, 2022-01, Vol.28, p.10760296211056648

2022

Volltextzugriff (PDF)

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

The oncologist (Dayton, Ohio), 2018-11, Vol.23 (11), p.1372-1381

2018

Volltextzugriff (PDF)

An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination

Clinical and Applied Thrombosis/Hemostasis, 2021, Vol.27, p.10760296211021498

2021

Volltextzugriff (PDF)

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Thrombosis and haemostasis, 2020-12, Vol.120 (12), p.1680-1690

2020

Volltextzugriff (PDF)

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

International journal of oncology, 2017-12, Vol.51 (6), p.1793-1800

2017

Volltextzugriff (PDF)

Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer

Thrombosis research, 2020-07, Vol.191, p.S50-S57

2020

Volltextzugriff (PDF)

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

Thrombosis research, 2020-03, Vol.187, p.170-179

2020

Volltextzugriff (PDF)

Perioperative Coagulation Profile in Major Liver Resection for Cancer: A Prospective Observational Study

Thrombosis and haemostasis, 2022-10, Vol.122 (10), p.1662-1672

2022

Volltextzugriff (PDF)

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms

Clinical and Applied Thrombosis/Hemostasis, 2022, Vol.28, p.10760296221097969-10760296221097969

2022

Volltextzugriff (PDF)

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Critical reviews in oncogenesis, 2017, Vol.22 (3-4), p.219-248

2017

Volltextzugriff (PDF)

Modelling of thrombin generation under flow in realistic left anterior descending geometries

Medical engineering & physics, 2017-12, Vol.50, p.50-58

2017

Volltextzugriff (PDF)

The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles

Thrombosis and haemostasis, 2012-06, Vol.107 (6), p.1044-1052

2012

Volltextzugriff (PDF)

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

International journal of oncology, 2017-12, Vol.51 (6), p.1747-1756

2017

Volltextzugriff (PDF)

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.10760296211033906-10760296211033906

2021

Volltextzugriff (PDF)

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Bulletin du cancer, 2016-09, Vol.103 (9), p.764-775

2016

Volltextzugriff (PDF)

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

TH open : companion journal to thrombosis and haemostasis, 2022-04, Vol.6 (2), p.e89-e95

2022

Volltextzugriff (PDF)

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

Thrombosis and haemostasis, 2021-08, Vol.121 (8), p.992-1007

2021

Volltextzugriff (PDF)

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Therapeutics and clinical risk management, 2014-01, Vol.10 (default), p.423-436

2014

Volltextzugriff (PDF)

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Thrombosis journal, 2017-03, Vol.15 (1), p.9-9, Article 9

2017

Volltextzugriff (PDF)

Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin

Thrombosis research, 2015-12, Vol.136 (6), p.1273-1279

2015

Volltextzugriff (PDF)

1 – 25 von 143

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(141)
Buchkapitel
(2)

Sprache

Englisch
(136)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hematological findings and complications of COVID‐19

A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS–Cancer‐Associated Thrombosis Study

Updated clinical models for VTE prediction in hospitalized medical patients

Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Thrombosis: The Observational ROADMAP‐CAT Study

An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination

Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19

Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer

Overview of risk assessment models for venous thromboembolism in ambulatory patients with cancer

Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells

Perioperative Coagulation Profile in Major Liver Resection for Cancer: A Prospective Observational Study

Thrombotic and Hemorrhagic Issues Associated with Myeloproliferative Neoplasms

The Role of Tissue Factor in Cancer-Related Hypercoagulability, Tumor Growth, Angiogenesis and Metastasis and Future Therapeutic Strategies

Modelling of thrombin generation under flow in realistic left anterior descending geometries

The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles

Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells

Combined Vaccination Approaches for COVID-19. Will These Improve the Efficacy Spectrum?

Risque thromboembolique en oncologie : réalités, actualités et perspectives

Public Awareness on Cancer-Associated Thrombosis among the Greek Population: First Findings from the ROADMAP-CAT Awareness Study

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin

Aktive Filter

Suchergebnisse filtern